NAB2
Basic information
Region (hg38): 12:57089043-57095476
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NAB2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 20 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 1 | 1 |
Variants in NAB2
This is a list of pathogenic ClinVar variants found in the NAB2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-57089335-A-C | not specified | Uncertain significance (Jun 17, 2024) | ||
12-57091127-C-G | not specified | Uncertain significance (Feb 02, 2024) | ||
12-57091136-G-A | not specified | Uncertain significance (May 23, 2023) | ||
12-57091245-C-T | Likely benign (Jan 01, 2023) | |||
12-57091246-G-A | not specified | Uncertain significance (Apr 23, 2024) | ||
12-57091354-G-C | not specified | Uncertain significance (Nov 10, 2022) | ||
12-57091477-G-A | not specified | Uncertain significance (Dec 28, 2023) | ||
12-57091486-G-C | not specified | Uncertain significance (Aug 23, 2021) | ||
12-57091502-G-A | not specified | Uncertain significance (Jan 05, 2022) | ||
12-57091511-G-C | not specified | Uncertain significance (Dec 13, 2022) | ||
12-57091631-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
12-57091658-C-G | not specified | Uncertain significance (Sep 26, 2024) | ||
12-57091661-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
12-57091672-C-T | Benign (Jul 21, 2018) | |||
12-57091718-C-G | not specified | Uncertain significance (Jul 30, 2023) | ||
12-57091738-G-T | not specified | Uncertain significance (Aug 15, 2024) | ||
12-57091769-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
12-57091801-C-T | not specified | Uncertain significance (Nov 15, 2023) | ||
12-57092578-C-A | not specified | Uncertain significance (Aug 13, 2021) | ||
12-57092955-A-G | not specified | Uncertain significance (Feb 12, 2024) | ||
12-57093080-C-A | not specified | Uncertain significance (Jul 26, 2024) | ||
12-57093118-A-G | not specified | Uncertain significance (Dec 13, 2023) | ||
12-57093187-A-C | not specified | Uncertain significance (Aug 31, 2022) | ||
12-57093514-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
12-57093524-G-A | not specified | Uncertain significance (Feb 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NAB2 | protein_coding | protein_coding | ENST00000300131 | 7 | 6583 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.567 | 0.433 | 125737 | 0 | 3 | 125740 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.01 | 168 | 319 | 0.526 | 0.0000197 | 3315 |
Missense in Polyphen | 36 | 114.52 | 0.31436 | 1159 | ||
Synonymous | -1.94 | 162 | 133 | 1.21 | 0.00000787 | 1145 |
Loss of Function | 3.30 | 4 | 19.9 | 0.201 | 0.00000118 | 218 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.000120 | 0.0000993 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000544 | 0.0000462 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a transcriptional repressor for zinc finger transcription factors EGR1 and EGR2. Isoform 2 lacks repression ability (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.165
Intolerance Scores
- loftool
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.92
Haploinsufficiency Scores
- pHI
- 0.734
- hipred
- Y
- hipred_score
- 0.775
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.992
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nab2
- Phenotype
- normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; respiratory system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- endochondral ossification;regulation of transcription, DNA-templated;nervous system development;cell population proliferation;Schwann cell differentiation;negative regulation of transcription by RNA polymerase III;myelination;regulation of epidermis development;positive regulation of tau-protein kinase activity
- Cellular component
- nucleus
- Molecular function
- transcription corepressor activity;protein binding;transcription factor binding;identical protein binding